Cargando…
The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy
PURPOSE: Laparoscopic nephrectomy (LN) has become the preferred method for renal cell carcinoma (RCC). Adequate preoperative assessment or intraoperative navigation is key to the successful implementation of LN. The aim of this study was to evaluate the clinical application value of mixed‐reality–as...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402835/ https://www.ncbi.nlm.nih.gov/pubmed/32543025 http://dx.doi.org/10.1002/cam4.3189 |
_version_ | 1783566834265489408 |
---|---|
author | Li, Guan Dong, Jie Wang, Jinbao Cao, Dongbing Zhang, Xin Cao, Zhiqiang Lu, Guangming |
author_facet | Li, Guan Dong, Jie Wang, Jinbao Cao, Dongbing Zhang, Xin Cao, Zhiqiang Lu, Guangming |
author_sort | Li, Guan |
collection | PubMed |
description | PURPOSE: Laparoscopic nephrectomy (LN) has become the preferred method for renal cell carcinoma (RCC). Adequate preoperative assessment or intraoperative navigation is key to the successful implementation of LN. The aim of this study was to evaluate the clinical application value of mixed‐reality–assisted surgical navigation (MRASN) in LN. PATIENTS AND METHODS: A total of 100 patients with stage T1N0M0 renal tumors who underwent laparoscopic partial nephrectomy (LPN) or laparoscopic radical nephrectomy (LRN) were prospectively enrolled and divided into a mixed‐reality‐assisted laparoscopic nephrectomy (MRALN) group (n = 50) and a non–mixed‐reality‐assisted laparoscopic nephrectomy (non‐MRALN) group (n = 50). All patients underwent renal contrast‐enhanced CT scans. The CT DICOM data of all patients in the MRALN group were imported into the mixed‐reality (MR) postprocessing workstation and underwent holographic three‐dimensional visualization (V3D) modeling and MR displayed, respectively. We adopted the Likert scale to evaluate the clinical application value of MRASN. The consistency of evaluators was assessed using the Cohen kappa coefficient (k). RESULTS: No significant differences in patient demographic indicators between the MRALN group and the non‐MRALN group (P > .05). The subjective score of MRASN clinical application value in operative plan formulation, intraoperative navigation, remote consultation, teaching guidance, and doctor‐patient communication were higher in the MRASN group than in the non‐MRASN group (all P < .001). There were significantly more patients for whom LPN was successfully implemented in the MRALN group than in the non‐MRALN group (82% vs 46%, P < .001). The MRALN group had a shorter operative time (OT) and warm ischemia time (WIT) and less estimated blood loss (EBL) than the non‐MRALN group (all P < .001). CONCLUSION: MRASN is helpful for operative plan formulation, intraoperative navigation, remote consultation, teaching guidance, and doctor‐patient communication. MRALN may effectively improve the successful implementation rate of LPN and reduce the OT, WIT, and EBL. |
format | Online Article Text |
id | pubmed-7402835 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74028352020-08-06 The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy Li, Guan Dong, Jie Wang, Jinbao Cao, Dongbing Zhang, Xin Cao, Zhiqiang Lu, Guangming Cancer Med Clinical Cancer Research PURPOSE: Laparoscopic nephrectomy (LN) has become the preferred method for renal cell carcinoma (RCC). Adequate preoperative assessment or intraoperative navigation is key to the successful implementation of LN. The aim of this study was to evaluate the clinical application value of mixed‐reality–assisted surgical navigation (MRASN) in LN. PATIENTS AND METHODS: A total of 100 patients with stage T1N0M0 renal tumors who underwent laparoscopic partial nephrectomy (LPN) or laparoscopic radical nephrectomy (LRN) were prospectively enrolled and divided into a mixed‐reality‐assisted laparoscopic nephrectomy (MRALN) group (n = 50) and a non–mixed‐reality‐assisted laparoscopic nephrectomy (non‐MRALN) group (n = 50). All patients underwent renal contrast‐enhanced CT scans. The CT DICOM data of all patients in the MRALN group were imported into the mixed‐reality (MR) postprocessing workstation and underwent holographic three‐dimensional visualization (V3D) modeling and MR displayed, respectively. We adopted the Likert scale to evaluate the clinical application value of MRASN. The consistency of evaluators was assessed using the Cohen kappa coefficient (k). RESULTS: No significant differences in patient demographic indicators between the MRALN group and the non‐MRALN group (P > .05). The subjective score of MRASN clinical application value in operative plan formulation, intraoperative navigation, remote consultation, teaching guidance, and doctor‐patient communication were higher in the MRASN group than in the non‐MRASN group (all P < .001). There were significantly more patients for whom LPN was successfully implemented in the MRALN group than in the non‐MRALN group (82% vs 46%, P < .001). The MRALN group had a shorter operative time (OT) and warm ischemia time (WIT) and less estimated blood loss (EBL) than the non‐MRALN group (all P < .001). CONCLUSION: MRASN is helpful for operative plan formulation, intraoperative navigation, remote consultation, teaching guidance, and doctor‐patient communication. MRALN may effectively improve the successful implementation rate of LPN and reduce the OT, WIT, and EBL. John Wiley and Sons Inc. 2020-06-15 /pmc/articles/PMC7402835/ /pubmed/32543025 http://dx.doi.org/10.1002/cam4.3189 Text en © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Li, Guan Dong, Jie Wang, Jinbao Cao, Dongbing Zhang, Xin Cao, Zhiqiang Lu, Guangming The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy |
title | The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy |
title_full | The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy |
title_fullStr | The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy |
title_full_unstemmed | The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy |
title_short | The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy |
title_sort | clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402835/ https://www.ncbi.nlm.nih.gov/pubmed/32543025 http://dx.doi.org/10.1002/cam4.3189 |
work_keys_str_mv | AT liguan theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT dongjie theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT wangjinbao theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT caodongbing theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT zhangxin theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT caozhiqiang theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT luguangming theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT liguan clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT dongjie clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT wangjinbao clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT caodongbing clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT zhangxin clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT caozhiqiang clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy AT luguangming clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy |